High citrulline-to-arginine ratio associated with blood pressure abnormalities in children with early chronic kidney disease

Circulation Journal

Volumn 77, Issue 1, 2013, Pages 181-187

  Lin, Ying Jui ^a   Hsu, Chien Ning ^b,c   Lo, Mao Hung ^a   Huang, Chien Fu ^a   Chien, Shao Ju ^a   Tain, You Lin ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Ambulatory blood pressure monitoring; Chronic kidney disease; Citrulline; Hypertension; Nitric oxide

Indexed keywords

6 N, N' DIMETHYLARGININE; ARGININE; ARGININOSUCCINATE LYASE; CITRULLINE; DIMETHYLARGININASE; N (G), N (G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE; ORNITHINE CARBAMOYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ARTICLE; BIOCHEMISTRY; BLOOD PRESSURE FLUCTUATION; BLOOD PRESSURE MONITORING; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MALE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ARGININE; BIOLOGICAL MARKERS; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; CITRULLINE; FEMALE; HUMANS; HYPERTENSION; MALE; RENAL INSUFFICIENCY, CHRONIC;

EID: 84871694069     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-12-0602     Document Type: Article

References (42)

1. Wilcox CS. Oxidative stress and nitric oxide deficiency in the kidney: A critical link to hypertension? Am J Physiol Regul Integr Comp Physiol 2005; 89: R913-R915.
2. Török J. Participation of nitric oxide in different models of experimental hypertension. Physiol Res 2008; 57: 813-825.
3. Baylis C. Nitric oxide synthase derangements and hypertension in kidney disease. Curr Opin Nephrol Hypertens 2012; 21: 1-6.
4. Klahr S, Morrissey J. L-arginine as a therapeutic tool in kidney disease. Semin Nephrol 2004; 24: 389-394.
5. Wu G, Morris SM Jr. Arginine metabolism: Nitric oxide and beyond. Biochem J 1998; 336: 1-17.
6. Tizianello A, De Ferrari G, Garibotto G, Gurreri G, Robaudo C. Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. J Clin Invest 1980; 65: 1162-1173.
7. Lau T, Owen W, Yu YM, Noviski N, Lyons J, Zurakowski D, et al. Arginine, citrulline, and nitric oxide metabolism in end-stage renal disease patients. J Clin Invest 2000; 105: 1217-1225.
8. Levillain O, Parvy P, Hassler C. Amino acid handling in uremic rats: Citrulline, a reliable marker of renal insufficiency and proximal tubular dysfunction. Metabolism 1997; 46: 611-618.
9. Cynober L, Moinard C, De Bandt JP. The 2009 ESPEN Sir David Cuthbertson. Citrulline: A new major signaling molecule or just another player in the pharmaconutrition game? Clin Nutr 2010; 29: 545-551.
10. van de Poll MC, Soeters PB, Deutz NE, Fearon KC, Dejong CH. Renal metabolism of amino acids: Its role in interorgan amino acid exchange. Am J Clin Nutr 2004; 79: 185-197.
11. Chen GF, Baylis C. In vivo renal arginine release is impaired throughout development of chronic kidney disease. Am J Physiol Renal Physiol 2010; 298: F95-F102.
12. Tain YL, Huang LT, Lin IC, Lau YT, Lin CY. Melatonin prevents hypertension and increased asymmetric dimethylarginine in young spontaneous hypertensive rats. J Pineal Res 2010; 49: 390-398.
13. Koeners MP, van Faassen EE, Wesseling S, de Sain-van der Velden M, Koomans HA, Braam B, et al. Maternal supplementation with citrulline increases renal nitric oxide in young spontaneously hypertensive rats and has long-term antihypertensive effects. Hypertension 2007; 50: 1077-1084.
14. Hsu CN, Huang LT, Lau YT, Lin CY, Tain YL. The combined ratios of L-arginine, asymmetric and symmetric dimethylarginine as biomarkers in spontaneously hypertensive rats. Transl Res 2012; 159: 90-98.
15. Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: Regulation and action. Pharmacol Res 2009; 60: 448-460.
16. Tain YL, Huang LT. Asymmetric dimethylarginine: Clinical application in pediatric medicine. J Formos Med Assoc 2011; 110: 70-77.
17. Bode-Boger SM, Scalera F, Ignarro LJ. The l-arginine paradox: Importance of the l-arginine/asymmetrical dimethylarginine ratio. Pharmacol Ther 2007; 114: 295-306.
18. Fliser D, Kronenberg F, Kielstein JT, Morath C, Bode-Böger SM, Haller H, et al. Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol 2005; 16: 2456-2461.
19. Wang D, Strandgaard S, Iversen J, Wilcox CS. Asymmetric dimethylarginine, oxidative stress, and vascular nitric oxide synthase in essential hypertension. Am J Physiol Regul Integr Comp Physiol 2009; 296: R195-R200.
20. Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Chronic Kidney Disease in Children Study Group: Blood pressure in children with chronic kidney disease: A report from the Chronic Kidney Disease in Children study. Hypertension 2008; 52: 631-637.
21. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, et al; CKiD Study Group. Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 2010; 21: 137-144.
22. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39: S1-S266.
23. Schwartz GJ, Muñoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, et al. New equations to estimate GFR in children with CKD. J Am Soc Nephrol 2009; 20: 629-637.
24. Hogg RJ, Furth S, Lemley KV, Portman R, Schwartz GJ, Coresh J, et al; National Kidney Foundation's Kidney Disease Outcomes Quality Initiative. Clinical practice guidelines for chronic kidney disease in children and adolescents: Evaluation, classification, and stratification. Pediatrics 2003; 111: 1416-1421.
25. Urbina E, Alpert B, Flynn J, Hayman L, Harshfield GA, Jacobson M, et al. Ambulatory blood pressure monitoring in children and adolescents: Recommendations for standard assessment: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee of the council on cardiovascular disease in the young and the council for high blood pressure research. Hypertension 2008; 52: 433-451.
26. Wuhl E, Witte K, Soergelm M, Mehls O, Schaefer F; German Working Group on Pediatric Hypertension. Distribution of 24-h ambulatory blood pressure in children: Normalized reference values and role of body dimensions. J Hypertens 2002; 20: 1995-2007.
27. Tain YL, Hsieh CS, Lin IC, Chen CC, Sheen JM, Huang LT. Effects of maternal L-citrulline supplementation on renal function and blood pressure in offspring exposed to maternal caloric restriction: The impact of nitric oxide pathway. Nitric Oxide 2010; 23: 34-41.
28. Curis E, Nicolis I, Moinard C, Osowska S, Zerrouk N, Bénazeth S, et al. Almost all about citrulline in mammals. Amino Acids 2005; 29: 177-205.
29. Wühl E, Hadtstein C, Mehls O, Schaefer F; ESCAPE Trial Group. Ultradian but not circadian blood pressure rhythms correlate with renal dysfunction in children with chronic renal failure. J Am Soc Nephrol 2005; 16: 746-754.
30. ESCAPE Trial Group; Wühl E, Trivelli A, Picca S, Litwin M, Peco- Antic A, Zurowska A, et al. Strict blood-pressure control and progression of renal failure in children. N Engl J Med 2009; 361: 1639-1650.
31. Frattola A, Parati G, Cuspidi C, Albini F, Mancia G. Prognostic value of 24-hour blood pressure variability. J Hypertens 1993; 11: 1133-1137.
32. Soylu A, Yazici M, Duzenli MA, Tokac M, Ozdemir K, Gok H. Relation between abnormalities in circadian blood pressure rhythm and target organ damage in normotensives. Circ J 2009; 73: 899-904.
33. Baylis C, Vallance P. Measurement of nitrite and nitrate levels in plasma and urine: What does this measure tell us about the activity of the endogenous nitric oxide system? Curr Opin Nephrol Hypertens 1998; 7: 59-62.
34. Siervo M, Stephan BC, Feelisch M, Bluck LJ. Measurement of in vivo nitric oxide synthesis in humans using stable isotopic methods: A systematic review. Free Radic Biol Med 2011; 51: 795-804.
35. Romero MJ, Platt DH, Caldwell RB, Caldwell RW. Therapeutic use of citrulline in cardiovascular disease. Cardiovasc Drug Rev 2006; 24: 275-290.
36. Figueroa A, Trivino JA, Sanchez-Gonzalez MA, Vicil F. Oral L-citrulline supplementation attenuates blood pressure response to cold pressor test in young men. Am J Hypertens 2010; 23: 12-16.
37. Figueroa A, Sanchez-Gonzalez MA, Perkins-Veazie PM, Arjmandi BH. Effects of watermelon supplementation on aortic blood pressure and wave reflection in individuals with prehypertension: A pilot study. Am J Hypertens 2011; 24: 40-44.
38. Manabe I. Chronic inflammation links cardiovascular, metabolic and renal diseases. Circ J 2011; 75: 2739-2748.
39. Heo KS, Fujiwara K, Abe J. Disturbed-flow-mediated vascular reactive oxygen species induce endothelial dysfunction. Circ J 2011; 75: 2722-2730.
40. Brooks ER, Langman CB, Wang S, Price HE, Hodges AL, Darling L, et al. Methylated arginine derivatives in children and adolescents with chronic kidney disease. Pediatr Nephrol 2009; 24: 129-134.
41. JCS Joint Working Group. Guidelines for the clinical use of 24 hour ambulatory blood pressure monitoring (ABPM) (JCS 2010): Digest version. Circ J 2012; 76: 508-519.
42. Weng KP, Hsieh KS, Huang SH, Lin CC. Oscillometric ambulatory blood pressure values in healthy children. Acta Paediatr Taiwan 2002; 43: 15-20.